The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension
Currently available noninvasive markers for assessing disease severity and mortality risk in pulmonary arterial hypertension (PAH) are unrelated to fundamental disease biology. Endostatin, an angiostatic peptide known to inhibit pulmonary artery endothelial cell migration, proliferation and survival...
Main Authors: | Catherine E. Simpson, Megan Griffiths, Jun Yang, Melanie K. Nies, R. Dhananjay Vaidya, Stephanie Brandal, Lisa J. Martin, Michael W. Pauciulo, Katie A. Lutz, Anna W. Coleman, Eric D. Austin, D. Dunbar Ivy, William C. Nichols, Allen D. Everett, Paul M. Hassoun, Rachel L. Damico |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2021-10-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/7/4/00378-2021.full |
Similar Items
-
COL18A1 genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association study
by: Catherine E. Simpson, et al.
Published: (2022-06-01) -
Insulin‐like growth factor binding Protein‐4: A novel indicator of pulmonary arterial hypertension severity and survival
by: Guillermo Torres, et al.
Published: (2023-04-01) -
Low‐affinity insulin‐like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survival
by: Guillermo Torres, et al.
Published: (2023-07-01) -
Proteomics discovery of pulmonary hypertension biomarkers: Insulin‐like growth factor binding proteins are associated with disease severity
by: Melanie K. Nies, et al.
Published: (2022-04-01) -
ANGIOGENIC AND ANGIOSTATIC CHEMOKINES LEVEL IN NORMAL SYNOVIAL FLUID
by: D. A. Zhebrun, et al.
Published: (2014-08-01)